Topic: How To Invest

Q: I am a long-time member, with most of my portfolio in stocks that you recommend. I would like your opinion of Sanofi, SNY on Nasdaq. Kind regards.

Article Excerpt

A: Sanofi (ADR), $52.11, symbol SNY on New York (ADRs outstanding: 2.5 billion; Market cap: $128.5 billion; www.sanofi.com) is a global pharmaceutical company. It offers a wide range of medicines, vaccines, and therapeutic solutions. Its sales break down as follows: pharmaceuticals, 71%; vaccines, 17%; and consumer healthcare, 12%. Geographically, sales are 38% in the U.S., 25% in Europe, and 37% in emerging markets/the rest of world. Sanofi’s main therapeutic areas/drugs include: Dupixent (a drug therapy designed to treat people six years and older suffering with moderate-to-severe atopic eczema); Lantus (diabetes); Toujeo (diabetes); Plavix (a blood thinner used to reduce the risk of blood clots); Lovenox (an anticoagulant that helps prevent the formation of blood clots); and Jevtana (prostate cancer). In January 2017, the company sold its animal health business to Boehringer Ingelheim in exchange for that company’s consumer healthcare business. In addition, Sanofi received 4.3 billion euros ($5.2 billion U.S.) cash. Over the last five years, overall sales have risen 24.4%, from 35.5 billion…